BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 17600280)

  • 1. Thymosin beta4 is cardioprotective after myocardial infarction.
    Srivastava D; Saxena A; Michael Dimaio J; Bock-Marquette I
    Ann N Y Acad Sci; 2007 Sep; 1112():161-70. PubMed ID: 17600280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thymosin beta4 activates integrin-linked kinase and promotes cardiac cell migration, survival and cardiac repair.
    Bock-Marquette I; Saxena A; White MD; Dimaio JM; Srivastava D
    Nature; 2004 Nov; 432(7016):466-72. PubMed ID: 15565145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiac repair with thymosin β4 and cardiac reprogramming factors.
    Srivastava D; Ieda M; Fu J; Qian L
    Ann N Y Acad Sci; 2012 Oct; 1270():66-72. PubMed ID: 23050819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. C-terminal variable AGES domain of Thymosin β4: the molecule's primary contribution in support of post-ischemic cardiac function and repair.
    Hinkel R; Ball HL; DiMaio JM; Shrivastava S; Thatcher JE; Singh AN; Sun X; Faskerti G; Olson EN; Kupatt C; Bock-Marquette I
    J Mol Cell Cardiol; 2015 Oct; 87():113-25. PubMed ID: 26255251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thymosin β4-mediated protective effects in the heart.
    Hinkel R; Klett K; Bähr A; Kupatt C
    Expert Opin Biol Ther; 2018 Jul; 18(sup1):121-129. PubMed ID: 30063857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Significance of thymosin β4 and implication of PINCH-1-ILK-α-parvin (PIP) complex in human dilated cardiomyopathy.
    Sopko N; Qin Y; Finan A; Dadabayev A; Chigurupati S; Qin J; Penn MS; Gupta S
    PLoS One; 2011; 6(5):e20184. PubMed ID: 21625516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular and cellular mechanisms of thymosin β4-mediated cardioprotection.
    Hinkel R; Trenkwalder T; Kupatt C
    Ann N Y Acad Sci; 2012 Oct; 1269():102-9. PubMed ID: 23045977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thymosin beta4 and Ac-SDKP: tools to mend a broken heart.
    Rossdeutsch A; Smart N; Riley PR
    J Mol Med (Berl); 2008 Jan; 86(1):29-35. PubMed ID: 17701149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thymosin β4: multiple functions in protection, repair and regeneration of the mammalian heart.
    Bollini S; Riley PR; Smart N
    Expert Opin Biol Ther; 2015; 15 Suppl 1():S163-74. PubMed ID: 26094634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thymosin beta4: a key factor for protective effects of eEPCs in acute and chronic ischemia.
    Hinkel R; Bock-Marquette I; Hatzopoulos AK; Kupatt C
    Ann N Y Acad Sci; 2010 Apr; 1194():105-11. PubMed ID: 20536456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thymosin β4 released from functionalized self-assembling peptide activates epicardium and enhances repair of infarcted myocardium.
    Wang YL; Yu SN; Shen HR; Wang HJ; Wu XP; Wang QL; Zhou B; Tan YZ
    Theranostics; 2021; 11(9):4262-4280. PubMed ID: 33754060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thymosin β4: potential to treat epidermolysis bullosa and other severe dermal injuries.
    Yang WS; Kang S; Sung J; Kleinman HK
    Eur J Dermatol; 2019 Oct; 29(5):459-467. PubMed ID: 31649007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic potential of thymosin β4 in myocardial infarct and heart failure.
    Stark C; Taimen P; Tarkia M; Pärkkä J; Saraste A; Alastalo TP; Savunen T; Koskenvuo J
    Ann N Y Acad Sci; 2012 Oct; 1269():117-24. PubMed ID: 23045979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic potential of thymosin-beta4 and its derivative N-acetyl-seryl-aspartyl-lysyl-proline (Ac-SDKP) in cardiac healing after infarction.
    Cavasin MA
    Am J Cardiovasc Drugs; 2006; 6(5):305-11. PubMed ID: 17083265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thymosin β4: Roles in Development, Repair, and Engineering of the Cardiovascular System.
    Marks ED; Kumar A
    Vitam Horm; 2016; 102():227-49. PubMed ID: 27450737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thymosin beta4: structure, function, and biological properties supporting current and future clinical applications.
    Crockford D; Turjman N; Allan C; Angel J
    Ann N Y Acad Sci; 2010 Apr; 1194():179-89. PubMed ID: 20536467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biological activities of thymosin beta4 defined by active sites in short peptide sequences.
    Sosne G; Qiu P; Goldstein AL; Wheater M
    FASEB J; 2010 Jul; 24(7):2144-51. PubMed ID: 20179146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Controlled release of thymosin β4 from injected collagen-chitosan hydrogels promotes angiogenesis and prevents tissue loss after myocardial infarction.
    Chiu LL; Reis LA; Momen A; Radisic M
    Regen Med; 2012 Jul; 7(4):523-33. PubMed ID: 22817626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thymosin beta4 mediated PKC activation is essential to initiate the embryonic coronary developmental program and epicardial progenitor cell activation in adult mice in vivo.
    Bock-Marquette I; Shrivastava S; Pipes GC; Thatcher JE; Blystone A; Shelton JM; Galindo CL; Melegh B; Srivastava D; Olson EN; DiMaio JM
    J Mol Cell Cardiol; 2009 May; 46(5):728-38. PubMed ID: 19358334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Biotechnological production of acetylated thymosin beta4].
    Beĭrakhova KA; Stepanenko VN; Miroshnikov AI; Esipov RS
    Bioorg Khim; 2011; 37(2):223-32. PubMed ID: 21721255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.